About the medicine
- Active ingredients
- Ranibizumab
- INN
- Ранибизумаб
- Strength
- 10 мг
- Dosage form
- Раствор для внутриглазного введения
- Manufacturer
- Новартис Фарма Штейн АГ (Швейцария)
- Dispensing
- Prescription only
- Registration certificate
- РК-ЛС-5№016259
- Registered
- 24 Jun 2020
- Registration valid until
- 31 Dec 2027
- Shelf life
- 3 год
- ATC code
- S01LA — Antineovascularisation agents
- Country of registration
- Kazakhstan
Packs 1
- По 0,23 мл во флаконе из стекла. По 1 флакону, 1 игле, снабженной фильтром для извлечения препарата из флакона, в пачке из картона.
Package leaflet
There is no leaflet with these active ingredients in the reference yet. Read the leaflet in the pack and ask a doctor or pharmacist.
Other forms and manufacturers
This is reference information and does not replace a doctor's advice. Do not self-medicate: read the leaflet and ask a specialist before use.
Source: State Register of Medicines of the Republic of Kazakhstan (register.ndda.kz).